semaglutide eu Novo Nordisk wins approval for Wegovy weight-loss pill Novo Nordisk Secures EU Approval

Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.

Pharma and telehealth weight loss drug players should also provide transparent data on how many people experience which side effects when taking a GLP-1, while working with social media platforms to flag misleading content about medication efficacy and safety.

Want to travel while on GLP-1 medications

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1

3